Eunsung Global (CEO Lee Ki-se), a medical aesthetic medical device specialist, has received certification from the Brazilian National Sanitary Surveillance Agency (ANVISA) for its high-frequency equipment, Duet V. This achievement follows the US Food and Drug Administration (FDA) certification in January, and shows that Duet V’s technological prowess and stability are continuously being recognized in the global market.
'Duet V' is based on 4MHz high-frequency (RF) energy, and focuses heat on the dermis layer deeper than the surface, which is effective for collagen remodeling and elasticity improvement. Unlike the 6.78MHz high-frequency devices that have been recently released on the market, it is characterized by being able to deliver energy to relatively deeper skin layers. In particular, since there is less heat transfer to the epidermis, it has the advantage of not requiring a separate cooling system.
Duet V supports various treatment modes such as Shot and Rubbing by applying Thermal and Fractional dual systems, and allows customized treatment with 5 types of thermal tips and 2 types of fractional tips. In addition, treatment safety has been improved through temperature and contact sensors.
An official from Eunseong Global stated, “By obtaining certification from the US FDA and Brazil’s ANVISA earlier this year, we have proven that Duet V is officially recognized as a device in major global markets,” adding, “We will continue to expand our global certifications and leap forward as a medical aesthetic brand that leads the global market through continuous product innovation.”
- See more related articles
You must be logged in to post a comment.